Loading...
Loading...
By Sergio Arturo Lievano Madrigal - Mon, 09/07/2026 - 08:13
Faster clinical trial approvals and over US$643 million in pharma investment are positioning Mexico as a nearshoring manufacturing hub.
https://mexicobusiness.news/tag/boehringer-ingelheim
More Health
By Sergio Arturo Lievano Madrigal - Thu, 07/30/2026 - 16:31
This week, ISSSTE expands clinics, COFEPRIS advances trial reform, and AI reshapes oncology and digital health. This and more in the weekly roundup.
By Sergio Arturo Lievano Madrigal - Thu, 07/30/2026 - 12:56
Boehringer Ingelheim's 16.2% 1H26 sales growth coincides with a 22% rise in its Mexico clinical research investment for the year.
By MBN Staff - Fri, 05/29/2026 - 19:54
Mexico’s healthcare system is modernizing by investing in pharmaceutical manufacturing and clinical research. This is The Week in Health!
By Sergio Arturo Lievano Madrigal - Wed, 05/27/2026 - 09:24
Global pharmaceutical companies are expanding clinical research investment in Mexico, strengthening the country’s role as a regional innovation hub.
By Sofía Garduño - Wed, 01/28/2026 - 08:16
Mexico’s Ministry of Health calls for early diabetes prevention to cut risks, stressing primary care and lifestyle changes.
By Sofía Garduño - Fri, 11/28/2025 - 09:35
Boehringer Ingelheim expands its partnership with Clínicas del Azúcar to open four new diabetes care centers in Mexico.
By Sofía Garduño - Thu, 08/14/2025 - 10:42
This week, Grupo OMNI buys Marzam, Boehringer expands its Xochimilco plant, and Novartis reports positive Phase III results for Sjögren’s drug.
By MBN Staff - Tue, 08/12/2025 - 09:32
Boehringer Ingelheim invests MX$3.5 billion (US$188 million) to expand its Xochimilco plant, boosting production and exports globally.
By Aura Moreno - Thu, 08/07/2025 - 12:38
Mexico attracts US$643 million in pharma investment to boost research, production, and exports under Sheinbaum’s strategy for health sovereignty.
By Fernando Mares - Thu, 08/07/2025 - 12:24
Four pharmaceutical companies will invest MX$12 billion to expand their production and research capacity, aligning with Plan México.
